Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04739670
Title Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer (BELLA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Peter MacCallum Cancer Centre, Australia
Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST